
September 26, 2025
Events
New
PMDA-ATC Pharmaceuticals Review Webinar 2025 applications open
September 26, 2025
Events
New
PMDA-ATC MRCT/GCP Inspection Seminar 2026 applications open
September 22, 2025
Review
New
English Translation of Review Report: Rozebalamin
September 19, 2025
Safety
PMDA Risk Communications: Lubiprostone, etc. posted
September 19, 2025
Other
Recent Publications by PMDA Staff updated
September 18, 2025
Safety
PMDA Alert for Proper Use of Drugs: No. 7 Compliance with Measurement of Blood Lithium Levels during Treatment with Lithium Carbonate (revision) posted
September 17, 2025
Safety
Revisions of PRECAUTIONS: Tarlatamab (genetical recombination) posted
September 19, 2025
Drug
IVD
PMDA Risk Communications: Lubiprostone, etc. posted
September 18, 2025
Drug
Devices
Regen.
PMDA Alert for Proper Use of Drugs: No. 7 Compliance with Measurement of Blood Lithium Levels during Treatment with Lithium Carbonate (revision) posted
September 17, 2025
Drug
IVD
Revisions of PRECAUTIONS: Tarlatamab (genetical recombination) posted
Currently, there is no applicable information.
Currently, there is no applicable information.